Immunosuppression

LONDON — September 21, 2026 PureTech Health announced the successful completion of an End-of-Phase 1 meeting with the U.S....

SEATTLE, July 13, 2026 Sana Biotechnology announced the publication of long-term clinical findings in The New England Journal of...

Pratteln, Switzerland, July 1, 2026 Santhera Pharmaceuticals announced positive topline findings from a Phase 1 clinical study of AGAMREE®...

SEATTLE, July 1, 2026 Sana Biotechnology, Inc. announced that new clinical data from a first-in-human investigator-sponsored study evaluating UP421,...